https://lipidbank.jp/mediawiki/index.php?action=history&feed=atom&title=LBF20307HO01 2026-04-30T18:10:59Z Revision history for this page on the wiki MediaWiki 1.43.0 https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53822&oldid=prev 2010-10-21T07:21:13Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:21, 21 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-Hydroxy- (8-<del style="font-weight: bold; text-decoration: none;">cis</del>,<del style="font-weight: bold; text-decoration: none;">11</del>-<del style="font-weight: bold; text-decoration: none;">cis,</del>13<del style="font-weight: bold; text-decoration: none;">-trans</del>) -eicosatrienoic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-Hydroxy- (<ins style="font-weight: bold; text-decoration: none;">cis-</ins>8<ins style="font-weight: bold; text-decoration: none;">,cis</ins>-<ins style="font-weight: bold; text-decoration: none;">11</ins>,<ins style="font-weight: bold; text-decoration: none;">trans</ins>-13) -eicosatrienoic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-Hydroxy- (8Z,11Z,13E) -eicosatrienoic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-Hydroxy- (8Z,11Z,13E) -eicosatrienoic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53821:rev-53822:php=table --> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53821&oldid=prev 2010-06-02T07:24:25Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:24, 2 June 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-Hydroxy- (8-cis,11-cis,13-trans) -<del style="font-weight: bold; text-decoration: none;">icosatrienoic </del>acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-Hydroxy- (8-cis,11-cis,13-trans) -<ins style="font-weight: bold; text-decoration: none;">eicosatrienoic </ins>acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-Hydroxy- (8Z,11Z,13E) -eicosatrienoic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-Hydroxy- (8Z,11Z,13E) -eicosatrienoic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53820&oldid=prev 2010-05-28T05:30:24Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 14:30, 28 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-<del style="font-weight: bold; text-decoration: none;">hydroxy</del>-<del style="font-weight: bold; text-decoration: none;">8Z</del>,<del style="font-weight: bold; text-decoration: none;">11Z</del>,<del style="font-weight: bold; text-decoration: none;">13E</del>-icosatrienoic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-<ins style="font-weight: bold; text-decoration: none;">Hydroxy</ins>- <ins style="font-weight: bold; text-decoration: none;">(8-cis</ins>,<ins style="font-weight: bold; text-decoration: none;">11-cis</ins>,<ins style="font-weight: bold; text-decoration: none;">13-trans) </ins>-icosatrienoic acid</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-<del style="font-weight: bold; text-decoration: none;">hydroxy</del>-8Z,11Z,13E-eicosatrienoic acid&amp;&amp;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-<ins style="font-weight: bold; text-decoration: none;">Hydroxy</ins>- <ins style="font-weight: bold; text-decoration: none;">(</ins>8Z,11Z,13E<ins style="font-weight: bold; text-decoration: none;">) </ins>-eicosatrienoic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=15(S)-HETrE is a hydroxy fatty acid derived from dihomo- &amp;gamma; -linolenic acid.</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=15(S)-HETrE is a hydroxy fatty acid derived from dihomo- &amp;gamma; -linolenic acid.</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53819&oldid=prev 2010-05-11T02:53:41Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 11:53, 11 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=DFA8144</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03050007</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-hydroxy-8Z,11Z,13E-<del style="font-weight: bold; text-decoration: none;">eicosatrienoic </del>acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=15S-hydroxy-8Z,11Z,13E-<ins style="font-weight: bold; text-decoration: none;">icosatrienoic </ins>acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-hydroxy-8Z,11Z,13E-eicosatrienoic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-hydroxy-8Z,11Z,13E-eicosatrienoic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53818&oldid=prev 2010-05-10T08:48:08Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:48, 10 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l9">Line 9:</td> <td colspan="2" class="diff-lineno">Line 9:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-hydroxy-8Z,11Z,13E-eicosatrienoic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;15S-hydroxy-8Z,11Z,13E-eicosatrienoic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|UV Spectra= lambda max: 235nm  epsilon : 23,000</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Source=15(S)-HETrE is a hydroxy fatty acid derived from dihomo- gamma -linolenic acid.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Source=15(S)-HETrE is a hydroxy fatty acid derived from dihomo- <ins style="font-weight: bold; text-decoration: none;">&amp;</ins>gamma<ins style="font-weight: bold; text-decoration: none;">; </ins>-linolenic acid.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Chemical Synthesis=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  &amp;mu; M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 &amp;mu; M (arachidonic acid concentration of 60 &amp;mu; M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 <ins style="font-weight: bold; text-decoration: none;">&amp;</ins>mu<ins style="font-weight: bold; text-decoration: none;">; </ins>M at an arachidonic acid concentration of 5  &amp;mu; M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 &amp;mu; M (arachidonic acid concentration of 60 &amp;mu; M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53817&oldid=prev 2010-05-10T08:47:13Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:47, 10 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13">Line 13:</td> <td colspan="2" class="diff-lineno">Line 13:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  mu M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 &amp;mu; M (arachidonic acid concentration of 60 mu M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  <ins style="font-weight: bold; text-decoration: none;">&amp;</ins>mu<ins style="font-weight: bold; text-decoration: none;">; </ins>M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 &amp;mu; M (arachidonic acid concentration of 60 <ins style="font-weight: bold; text-decoration: none;">&amp;</ins>mu<ins style="font-weight: bold; text-decoration: none;">; </ins>M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53816&oldid=prev 2010-05-10T08:43:25Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:43, 10 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13">Line 13:</td> <td colspan="2" class="diff-lineno">Line 13:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  mu M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 &amp;<del style="font-weight: bold; text-decoration: none;">#924 </del>M (arachidonic acid concentration of 60 mu M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  mu M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 &amp;<ins style="font-weight: bold; text-decoration: none;">mu; </ins>M (arachidonic acid concentration of 60 mu M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53815&oldid=prev 2010-05-10T08:41:11Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:41, 10 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13">Line 13:</td> <td colspan="2" class="diff-lineno">Line 13:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  mu M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 <del style="font-weight: bold; text-decoration: none;">micro </del>M (arachidonic acid concentration of 60 mu M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  mu M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 <ins style="font-weight: bold; text-decoration: none;">&amp;#924 </ins>M (arachidonic acid concentration of 60 mu M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53814&oldid=prev 2010-05-10T08:37:58Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:37, 10 May 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13">Line 13:</td> <td colspan="2" class="diff-lineno">Line 13:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Metabolism=</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Symbol=15(S)-HETrE</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  mu M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 <del style="font-weight: bold; text-decoration: none;">mu </del>M (arachidonic acid concentration of 60 mu M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|Biological Activity=Compared to a series of hydroxypolyenoic fatty acids, 15(S)-HETrE is a more potent inhibitor of human 5-lipoxygenase from polymorphonuclear leukocytes having an IC_{50} of 4.6 mu M at an arachidonic acid concentration of 5  mu M [[Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911|{{RelationTable/GetFirstAuthor|Reference:Petrich_K:Ludwig_P:Kuhn_H:Schewe_T:,Biochem. J.,1996,314 (Pt 3),911}}]]. In rat basophilic leukemia cell lysates, 15(S)-HETrE inhibits 5-lypoxygenase with an IC_{50} of 77 <ins style="font-weight: bold; text-decoration: none;">micro </ins>M (arachidonic acid concentration of 60 mu M) [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]]. 15(S)-HETrE is 10- to 20-fold less potent than 15(S)-HETE and 15(S)-HpETE under these experimental conditions [[Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254|{{RelationTable/GetFirstAuthor|Reference:Haviv_F:Ratajczyk_JD:DeNet_RW:Martin_YC:Dyer_RD:Carter_GW:,J. Med. Chem.,1987,30,254}}]].</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Lipid/Footer}}</div></td></tr> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20307HO01&diff=53813&oldid=prev 2010-04-14T21:00:00Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <tr class="diff-title" lang="en"> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:00, 15 April 2010</td> </tr><tr><td colspan="2" class="diff-notice" lang="en"><div class="mw-diff-empty">(No difference)</div> </td></tr></table>

Editor